Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Medical Oncology Updates
Medical Oncology Updates
by test
Medical Oncology Updates Presentation by Mary Hil...
Precision Medicine Clinical Trial Designs
Precision Medicine Clinical Trial Designs
by luanne-stotts
2018 . AACR Annual Meeting. April 15, 2018 . Edwa...
Finding the Right Fit: Personalizing Treatment in Metastatic Castration-Resistant Prostate Cancer
Finding the Right Fit: Personalizing Treatment in Metastatic Castration-Resistant Prostate Cancer
by pamella-moone
This program will include a discussion of . off-l...
Drug Development : Basic
Drug Development : Basic
by myesha-ticknor
Overview of Clinical Trials. : Phase I-III. Patr...
Case Discussion A 52-year-old man initially presented with
Case Discussion A 52-year-old man initially presented with
by lois-ondreau
nonmuscle. -invasive . bladder cancer. He receive...
Biology of Sarcomas “ The
Biology of Sarcomas “ The
by faustina-dinatale
first thing that the general medical oncologist h...
A phase III trial of adjuvant capecitabine in breast cancer
A phase III trial of adjuvant capecitabine in breast cancer
by myesha-ticknor
(. CREATE-. X/JBCRG. -04. ). C. apecitabine . for...
Blinded Sample Size Re-estimation in a Phase III Study Inve
Blinded Sample Size Re-estimation in a Phase III Study Inve
by luanne-stotts
David Morgan (King’s College, London / Consulta...
How qualitative research contributes to evaluation
How qualitative research contributes to evaluation
by alida-meadow
Professor Alicia . O’Cathain. ScHARR. Universi...
David R.
David R.
by alida-meadow
Gandara. , MD. University of California, Davis . ...
in Paediatric Palliative Medicine
in Paediatric Palliative Medicine
by ariel
Research. Outline. Is research for me?. Share some...
Invex Therapeutics  Bell Potter Healthcare Conference
Invex Therapeutics  Bell Potter Healthcare Conference
by gabriella
26 November 2020. ASX Code: . IXC. Disclaimer. Thi...
NIH Small Business Programs
NIH Small Business Programs
by jacey
1. Chris . Sasiela, PhD, RAC. chris.sasiela@nih.go...
I-ACQUIRE: A Phase III Trial of ACQUIRE for infants
I-ACQUIRE: A Phase III Trial of ACQUIRE for infants
by joyce
with Perinatal Arterial Ischemic Stroke . and Hemi...
Estimating the dose-toxicity curve from completed Phase I studies
Estimating the dose-toxicity curve from completed Phase I studies
by isla
Alexia Iasonos, . Irina Ostrovnaya. Department of ...
Fifteen Cell TherapiesStem Cell Therapies in Phase III Clinical Trial
Fifteen Cell TherapiesStem Cell Therapies in Phase III Clinical Trial
by genevieve
By Brandy Sargent Editor, Cell Culture Dish www.ce...
Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung Function in
Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung Function in
by thomas
Professor Salman Siddiqui, Clinical Professor of A...
State of the Field Exploring 2015’s Top Ten List for the HIV Prevention Research Field
State of the Field Exploring 2015’s Top Ten List for the HIV Prevention Research Field
by brooke
Manju Chatani, Stacey Hannah, Mitchell Warren. Thu...
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
by bikersjoker
patients with . advanced breast . cancer and a ger...
Product Pipeline Neratinib
Product Pipeline Neratinib
by coursion
across the breast cancer therapy spectrum. Phase I...
State of the Field Exploring
State of the Field Exploring
by undialto
2015’s Top Ten List for the HIV Prevention Resea...
Antibodies, BiTEs , and CARs: the new ABC’s of Myeloma Therapy
Antibodies, BiTEs , and CARs: the new ABC’s of Myeloma Therapy
by aaron
June 6, 2019. Adam D. Cohen, MD. Director, Myelom...
Phase IB Trial of Carboxyamidotriazole Orotate
Phase IB Trial of Carboxyamidotriazole Orotate
by myesha-ticknor
(CTO) and . Temozolomide. for Recurrent Malignan...
Advances in Rheumatoid Arthritis Management
Advances in Rheumatoid Arthritis Management
by sherrill-nordquist
This program will include a discussion . of inves...
Investor presentation Paul Rennie, CEO
Investor presentation Paul Rennie, CEO
by alexa-scheidler
25 May, 2016. Company overview. Investor presenta...
Investor Presentation Seeking $500,000 Convertible Note Financing,
Investor Presentation Seeking $500,000 Convertible Note Financing,
by danika-pritchard
P. receding $13MM Series B Round . NON-CONFIDENT...
Methods Subjects : 18-65
Methods Subjects : 18-65
by faustina-dinatale
yo. w migraine . wwo. aura (defined by ICHD3bet...
Bruix J et al. Lancet 2017;389(10064):56-66.
Bruix J et al. Lancet 2017;389(10064):56-66.
by kittie-lecroy
Regorafenib. 160 mg/d. (n = 379). Placebo. (n = ...
Phase IB trial of carboxyamidotriazole
Phase IB trial of carboxyamidotriazole
by cheryl-pisano
orotate (CTO) and radiotherapy . with concurrent...
The ERP Boot Camp Time-Frequency Analysis
The ERP Boot Camp Time-Frequency Analysis
by lois-ondreau
Assumption: . The timing of the ERP signal is the...
New Perspectives in Treatment Strategies for Follicular Lymphoma
New Perspectives in Treatment Strategies for Follicular Lymphoma
by olivia-moreira
Introduction. Standard Frontline Therapy for FL. ...
My Experiences as an FDA Statistician
My Experiences as an FDA Statistician
by aaron
Yeh-Fong Chen, Ph.D. . FDA/CDER/OB/DB3. CBA 2016-...
Her-2 negative MBC
Her-2 negative MBC
by conchita-marotz
10/25/2016. Objectives. General principles. Endoc...
P re-
P re-
by conchita-marotz
I. schemic . C. onditioning for Intracranial . A....
Clinical Trial Protocol & Amendments
Clinical Trial Protocol & Amendments
by liane-varnes
William Petros, PharmD, FCCP. Professor, Schools ...
Breakout Session 4: Personalized Medicine and Subgroup Sele
Breakout Session 4: Personalized Medicine and Subgroup Sele
by trish-goza
Christopher . Jennison. , University of Bath. Rob...
Adapting for Success: The Genesis of Adaptive Designs
Adapting for Success: The Genesis of Adaptive Designs
by alida-meadow
Andy Grieve. SVP Clinical Trials Methodology, . I...
At The Cutting Edge
At The Cutting Edge
by lois-ondreau
of Developments in the Management of Hyperkalemia...
A Phase 2 Trial of the Efficacy and Safety of Evinacumab in Patients with Severe Hypertriglyceridem
A Phase 2 Trial of the Efficacy and Safety of Evinacumab in Patients with Severe Hypertriglyceridem
by cohen386
Robert S. Rosenson,. 1. Daniel Gaudet,. 2. Chris...
INTRODUCTION TO DRUG REGULATORY SYSTEM.
INTRODUCTION TO DRUG REGULATORY SYSTEM.
by levi903
Drug Regulation means the control of Drug by regul...